Fig. 1 · Structure
Documents & Downloads
Mono-(2-ethylhexyl) phthalate
Cat. No.
A71111
CAS
4376-20-9
Endogenous Metabolite
Mono-(2-ethylhexyl) phthalate (MEHP) serves as a significant endogenous metabolite of diethylhexyl phthalate (DEHP). MEHP is known to enhance fatty acid synthesis in hepatocytes through the modulation of gene and protein expression, thereby playing a critical role in the development of non-alcoholic fatty liver disease (NAFLD). This compound is valuable for research investigating metabolic disorders, liver function, and the impact of environmental phthalates on health.
In Stock
Free Aliquoting for Your Order
Tell us your preferred amount per vial. We’ll confirm the options.
Specifications
| Manufacturer | Adooq Bioscience |
|---|---|
| CAS Number | 4376-20-9 |
| Applications | Endogenous Metabolite |
| Formula | C16H22O4 |
| Molecular Weight | 278.34 |
| Synonyms | MEHP; Phthalic acid mono-2-ethylhexyl ester |
| SMILES | O=C(O)C1=CC=CC=C1C(OCC(CC)CCCC)=O |
Storage & Solubility
In Vitro Solubility
Reported Solubility
No reported solubility data are available for this product.
Preparing Stock Solutions
| Concentration | |
|---|---|
Values use four significant digits. Prepare to the final solution volume; this is not the volume of solvent to add.
Stock preparation is unavailable for this product molecular weight.
Calculated stock concentrations do not establish solvent solubility. Refer to the reported solubility data for experimental guidance.
Storage
Store powder at -20°C, keep desiccated.
In powder form, the chemical is stable for 36 months.
In solution, store at -20°C and use within 1 month to prevent loss of potency. Aliquot to avoid multiple freeze/thaw cycles.